CLINICAL_TRIALS
research
· 2024-06-14
Clinical Trial Update: A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
Summary
A completed survey in Japan evaluating how pharmacists utilize Risk Management Plan materials for ixazomib (NINLARO) with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Multiple Myeloma | Status: COMPLETED | Results posted: 2024-06-14